Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
Produktbild: Coronary Heart Disease in Women

Coronary Heart Disease in Women Prevention - Diagnosis - Therapy

Fr. 73.90

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

12.03.2003

Abbildungen

XVI, 47 illus., schwarz-weiss Illustrationen

Verlag

Springer Berlin

Seitenzahl

210

Maße (L/B/H)

19/12.7/1.3 cm

Gewicht

274 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-540-00128-7

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

12.03.2003

Abbildungen

XVI, 47 illus., schwarz-weiss Illustrationen

Verlag

Springer Berlin

Seitenzahl

210

Maße (L/B/H)

19/12.7/1.3 cm

Gewicht

274 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-540-00128-7

Herstelleradresse

Springer Nature Customer Service Center GmbH
Tiergartenstr. 17
69121 Heidelberg
DE
ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Coronary Heart Disease in Women
  • 1 Epidemiology.- Definition.- Gender-Specific Mortality Rates.- Morbidity and Mortality with Respect to Age and Gender.- Perception.- Mortality in Myocardial Infarction: Comparison Between Women and Men.- International Comparisons.- The “MONItoring Cardiovascular Disease” Project of the WHO (WHO MONICA Project).- 2 Cardiovascular Risk Factors and the Development of Coronary Heart Disease in Women Smoking.- Smoking.- Dyslipidemia.- Lipoprotein (a).- Diabetes Mellitus.- Insulin Resistance and Polycystic Ovary Syndrome.- Family History of Coronary Heart Disease or Genetic Disposition.- Hypertension.- Sedentary Lifestyle.- Obesity.- Homocysteine.- High sensitivity C-reactive Protein.- Risk Factors Unique to Women.- Menopause.- Oral Contraception.- 3 Pathophysiology of Coronary Heart Disease and the Effects of Estrogen.- Basics.- Plaque Formation and Significance of Plaques in CHD.- Effects of Estrogen.- Effect of Estrogen on Vascular Reactivity and Endothelial Function.- Effect of Estrogen on Lipid Metabolism.- Antioxidative Effect of Estrogen.- Effect of Estrogen on Inflammation.- Effect of Estrogen on Hemostasis.- 4 Stable Angina.- Definition and Pathophysiology of Angina Pectoris.- Diagnosis Based on Symptoms.- Prinzmetal’s or Variant Angina.- Syndrome X.- Diagnostic Evaluation.- Electrocardiogram.- Stress Testing, Including Stress Echocardiography and Nuclear Imaging.- Determination of Pretest Probability for CHD.- Selection of Stress Test.- Stress ECG.- Nuclear Imaging.- Stress Echocardiography.- Pharmacological Stress Tests.- Electron Beam Computed Tomography.- Magnetic Resonance Imaging.- Diagnostic Cardiac Catheterization.- Gender Differences in the Use of Diagnostic Cardiac Catheterizations and Percutaneous Coronary Intervention.- Medical Management.- Beta-blockers.- Nitrate.- Calcium Channel Blockers.- Percutaneous Coronary Intervention for Stable Angina.- Gender-Specific Success and Complication Rates for Balloon Angioplasty.- Gender-Specific Success and Complication Rates for Coronary Intervention with Stent Implantation.- Restenosis.- Rotablator Therapy, Directional Coronary Atherectomy, Laser Therapy.- Multivessel Coronary Intervention — When PCI? When Bypass Surgery?.- 5 Acute Myocardial Infarction.- Progression from Stable Coronary Heart Disease to Myocardial Infarction.- Epidemiology of Acute Myocardial Infarction.- Pathophysiology.- Clinical Presentation of Acute Myocardial Infarction.- Silent Myocardial Infarction.- Symptomatic Myocardial Infarction.- Criteria for the Diagnosis of Acute Myocardial Infarction.- Clinical Presentation.- Electrocardiogram.- Serum Markers of Cardiac Damage.- Creatine Kinase and the CK Isoenzyme CK-MB.- Troponin T and I.- Therapy.- Revascularization.- Thrombolytic Therapy.- Primary Percutaneous Transluminal Coronary Angioplasty.- Thrombolysis Versus Primary PTCA.- Rescue PTCA after Thrombolysis of Acute Myocardial Infarction.- Medical Therapy of Acute Myocardial Infarction.- Aspirin.- Beta-blockers.- Unfractionated Heparin.- Calcium Channel Blockers.- ACE Inhibitors.- Nitrates.- Complications.- Prognosis.- Mortality in Acute Myocardial Infarction (With and Without Thrombolysis).- Mortality in the Pre-thrombolytic Era (Mid-1960s to Early-1980s).- Mortality in the Thrombolytic Era (1980 to Present).- Influence of Gender on the Referral for Coronary Angiography in Patients with Acute Myocardial Infarction.- 6 Acute Coronary Syndromes.- Non-ST-Elevation Myocardial Infarction/Unstable Angina.- Definition.- Presentation.- Diagnosis.- Therapy.- Medical Therapy.- Aspirin.- Unfractionated Heparin.- Low-Molecular-Weight Heparin.- Glycoprotein IIb/IIIa Receptor Antagonists.- Nitrates.- Beta-blocker.- Calcium Channel Blocker.- Interventional Therapy.- 7 Coronary Artery Bypass Surgery.- Operative Mortality.- Complications Associated with CABG.- Long-Term Outcomes.- Indication for CABG Surgery.- Comparison of CABG with Multivessel Angioplasty.- 8 Primary and Secondary Prevention of Coronary Heart Disease.- Class I Interventions.- Treatment of Hyperlipidemia.- Diet.- Medical Therapy of Dyslipidemia.- Primary Prevention Trials.- Primary Prevention with Estrogen.- Secondary Prevention Trials with Statins.- Secondary Prevention Trials with Medications Other Than Statins.- Treatment of Hypertension.- Aspirin.- Primary Prevention of CAD with Aspir.- Secondary Prevention with Aspirin.- Class II Interventions.- Physical Activity.- Primary Prevention Studies.- Secondary Prevention Studies.- Weight Reduction.- Alcohol.- Class III Interventions.- Antioxidants.- Vitamins E and C.- Beta-carotene.- 9 Hormone Replacement Therapy.- Hormone Replacement Therapy and Prevention of Coronary Heart Disease.- Observational Studies for Primary and Secondary Prevention.- Randomized Primary Prevention Trials.- Randomized Secondary Prevention Trials.- Clinical Implications of Hormone Replacement Therapy.- Combination Therapy.- Risk of Breast Cancer with HRT.- Risk of Ovarian Cancer with HRT.- Risk of Endometrial Cancer with HRT.- Risk of Deep Vein Thrombosis and Thromboembolic Events.- Estrogen and High Sensitivity C-reactive Protein.- Biological Mechanisms of Hormone Replacement Therapy.- Lipids and Antioxidant Effects of Estrogen.- Glucose Metabolism.- Hemostasis.- Vascular Reactivity.- Impact on Markers of Inflammation.- Selective Estrogen Receptor Modulators.- Soy Protein.- 10 Future Directions.